Keyphrases
Never-smokers
100%
Experience of Care
100%
Antitumor
100%
Decitabine
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Multicystic Peritoneal Mesothelioma
100%
Current Smokers
100%
Azacitidine
100%
Spontaneous Metastasis
100%
Surgical Patients
100%
Human Lung Adenocarcinoma
100%
Antitumor Effect
100%
Long-term Survival
100%
Smoking Status
100%
Hematological Cancer
100%
Cytotoxicity
100%
Epithelial Tumor Cells
100%
Primary Care
100%
Murine Xenograft Model
100%
DNA Demethylating Agents
100%
Specialty Care
100%
Patient Experience
100%
Non-surgical Patients
100%
Liver
100%
Hematologic Neoplasms
50%
Leukemia
50%
Associated Genes
50%
DNA Hypermethylation
50%
Re-expression
50%
DNA Methyltransferase Inhibitor
50%
Gene Silencing
50%
Promoter DNA
50%
Toxic Dose
50%
Promoter Methylation
50%
DNA Damage
50%
Cancer Stem-like
50%
Clinically Significant
50%
Regulatory Pathways
50%
Cancer Therapy
50%
Time Response
50%
Cancer Management
50%
Less Toxic
50%
Memory Response
50%
Therapy Approaches
50%
High Dose
50%
Rapid DNA
50%
A549 Cells
37%
Lung
37%
Euthanized
37%
Mixed Methods Design
33%
Medicine and Dentistry
Patient Experience
100%
Smoking
100%
Patient Care
100%
Long Term Survival
100%
Lung Adenocarcinoma
100%
Primary Health Care
100%
Peritoneum Mesothelioma
100%
Metastatic Carcinoma
100%
Non Small Cell Lung Cancer
100%
Xenograft
100%
Neoplasm
70%
Flank
60%
Splenectomy
50%
Peritonitis
50%
Implant
50%
Surgical History
50%
Injury
50%
Mesothelial Cell
50%
Endometriosis
50%
Cytokeratin AE1
50%
Patient History of Surgery
50%
Benign Tumor
50%
Computer Assisted Tomography
50%
Chronic Inflammation
50%
Health Care
50%
Medical History
50%
Mediastinal Lymph Node
40%
SCID Mouse
40%
Micrometastasis
40%
Primary Tumor
40%
Hazard Ratio
36%
Solid Malignant Neoplasm
20%
Intravenous Drug Administration
20%
Tail Vein
20%
Lymph Node Metastasis
20%
Lung Cancer
18%
Retrospective Study
9%
Univariate Analysis
9%
Survival Analysis
9%
Cancer Diagnosis
9%
Lung Alveolus Cell Carcinoma
9%
Anesthesiologist
9%
Adenocarcinoma
9%
